Trials / Terminated
TerminatedNCT05545735
The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days
Duration of Antibiotic Therapy for Early (DATE) Ventilator-Associated Pneumonia (VAP) Trial: A Surgical Infection Society Multicenter Randomized Clinical Trial of 4 vs. 7 Days of Definitive Antibiotic Therapy for Early VAP
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if the amount of antibiotics given for ventilator-associated pneumonia (VAP) can be decreased in order to reduce the risk of adverse effects associated with antibiotics, while at the same time ensuring the participant's safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Standard of Care Antibiotic Therapy | Antibiotics will be administered as per the standard of care orally via tablet |
Timeline
- Start date
- 2023-05-08
- Primary completion
- 2025-02-27
- Completion
- 2025-02-27
- First posted
- 2022-09-19
- Last updated
- 2026-01-16
- Results posted
- 2026-01-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05545735. Inclusion in this directory is not an endorsement.